MRSN
Price
$6.60
Change
-$0.25 (-3.65%)
Updated
Aug 1 closing price
Capitalization
32.9M
4 days until earnings call
SLXN
Price
$9.28
Change
-$5.66 (-37.88%)
Updated
Aug 1 closing price
Capitalization
5.38M
Interact to see
Advertisement

MRSN vs SLXN

Header iconMRSN vs SLXN Comparison
Open Charts MRSN vs SLXNBanner chart's image
Mersana Therapeutics
Price$6.60
Change-$0.25 (-3.65%)
Volume$110.63K
Capitalization32.9M
Silexion Therapeutics
Price$9.28
Change-$5.66 (-37.88%)
Volume$360.35K
Capitalization5.38M
MRSN vs SLXN Comparison Chart in %
Loading...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRSN vs. SLXN commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSN is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (MRSN: $6.60 vs. SLXN: $9.28)
Brand notoriety: MRSN and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRSN: 47% vs. SLXN: 340%
Market capitalization -- MRSN: $32.9M vs. SLXN: $5.38M
MRSN [@Biotechnology] is valued at $32.9M. SLXN’s [@Biotechnology] market capitalization is $5.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRSN’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • MRSN’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLXN is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRSN’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • MRSN’s TA Score: 4 bullish, 6 bearish.
  • SLXN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than MRSN.

Price Growth

MRSN (@Biotechnology) experienced а +2038.69% price change this week, while SLXN (@Biotechnology) price change was +974.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

MRSN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRSN($32.9M) has a higher market cap than SLXN($5.38M). SLXN YTD gains are higher at: -69.221 vs. MRSN (-81.538). SLXN has higher annual earnings (EBITDA): -16.96M vs. MRSN (-68.42M). SLXN has less debt than MRSN: SLXN (3.48M) vs MRSN (24.6M). MRSN has higher revenues than SLXN: MRSN (34M) vs SLXN (0).
MRSNSLXNMRSN / SLXN
Capitalization32.9M5.38M612%
EBITDA-68.42M-16.96M404%
Gain YTD-81.538-69.221118%
P/E RatioN/AN/A-
Revenue34M0-
Total CashN/AN/A-
Total Debt24.6M3.48M706%
FUNDAMENTALS RATINGS
MRSN: Fundamental Ratings
MRSN
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRSNSLXN
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
6%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
20%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
25%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 6 days ago
51%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 4 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COOP174.2618.54
+11.91%
Mr Cooper Group
ITRM0.73N/A
+0.11%
Iterum Therapeutics plc
ARAY1.28-0.03
-2.29%
Accuray
PYPL67.11-1.65
-2.40%
PayPal Holdings
TRUP46.21-1.20
-2.53%
Trupanion

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-37.88%
IMA - SLXN
59%
Loosely correlated
-3.46%
CELC - SLXN
50%
Loosely correlated
+1.90%
MRSN - SLXN
43%
Loosely correlated
-3.65%
QSI - SLXN
25%
Poorly correlated
-1.35%
CHRS - SLXN
25%
Poorly correlated
-6.64%
More